Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance TW Vanderah, LR Gardell, SE Burgess, M Ibrahim, A Dogrul, CM Zhong, ... Journal of Neuroscience 20 (18), 7074-7079, 2000 | 415 | 2000 |
Reversal of experimental neuropathic pain by T-type calcium channel blockers A Dogrul, LR Gardell, MH Ossipov, FC Tulunay, J Lai, F Porreca Pain 105 (1-2), 159-168, 2003 | 292 | 2003 |
Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors A Dogrul, MH Ossipov, F Porreca Brain research 1280, 52-59, 2009 | 256 | 2009 |
Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR5) antagonist, in experimental neuropathic pain in rats A Dogrul, MH Ossipov, J Lai, TP Malan Jr, F Porreca Neuroscience letters 292 (2), 115-118, 2000 | 144 | 2000 |
Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of … O Yanarates, A Dogrul, V Yildirim, A Sahin, A Sizlan, M Seyrek, Ö Akgül, ... The Journal of the American Society of Anesthesiologists 112 (3), 696-710, 2010 | 121 | 2010 |
Systemic morphine produce antinociception mediated by spinal 5‐HT7, but not 5‐HT1A and 5‐HT2 receptors in the spinal cord A Dogrul, M Seyrek British journal of pharmacology 149 (5), 498-505, 2006 | 111 | 2006 |
Topical cannabinoid enhances topical morphine antinociception O Yesilyurt, A Dogrul, H Gul, M Seyrek, O Kusmez, Y Ozkan, O Yildiz Pain 105 (1), 303-308, 2003 | 107 | 2003 |
The interaction between IL-1β and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice H Gul, O Yildiz, A Dogrul, O Yesilyurt, A Isimer Pain 89 (1), 39-45, 2000 | 91 | 2000 |
Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT7 receptors A Dogrul, M Seyrek, EO Akgul, T Cayci, S Kahraman, H Bolay European Journal of Pharmacology 677 (1-3), 93-101, 2012 | 89 | 2012 |
Topical clonidine antinociception A Dogrul, TI Uzbay Pain 111 (3), 385-391, 2004 | 89 | 2004 |
Topical cannabinoid antinociception: synergy with spinal sites A Dogrul, H Gul, A Akar, O Yildiz, F Bilgin, E Guzeldemir Pain 105 (1-2), 11-16, 2003 | 88 | 2003 |
L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective μ opioid agonist, but not to selective δ and κ agonist at the level of the … A Doğrul, Ö Yeşilyurt, A Işımer, ME Güzeldemir Pain 93 (1), 61-68, 2001 | 76 | 2001 |
The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac A Ulugöl, F Özyigit, Ö Yesilyurt, A Dogrul Anesthesia & Analgesia 102 (2), 443-447, 2006 | 74 | 2006 |
Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect A Doğrul, H Gül, O Yıldız, F Bilgin, ME Güzeldemir Neuroscience letters 368 (1), 82-86, 2004 | 66 | 2004 |
Systemic cannabinoids produce CB1-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT7 and 5-HT2A receptors M Seyrek, S Kahraman, MS Deveci, O Yesilyurt, A Dogrul European journal of pharmacology 649 (1-3), 183-194, 2010 | 64 | 2010 |
The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test A Dogrul, SE Gülmez, MS Deveci, H Gul, MH Ossipov, F Porreca, ... Anesthesia & Analgesia 104 (4), 927-935, 2007 | 64 | 2007 |
Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice A Dogrul, H Gul, O Yesilyurt, UH Ulas, O Yildiz Acta diabetologica 48, 135-142, 2011 | 63 | 2011 |
Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance A Dogrul, EJ Bilsky, MH Ossipov, J Lai, F Porreca Anesthesia & Analgesia 101 (6), 1730-1735, 2005 | 62 | 2005 |
The involvement of nitric oxide in the analgesic effects of ketamine F Bulutcu, A Dogrul, MO Güç Life Sciences 71 (7), 841-853, 2002 | 61 | 2002 |
Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception A Dogrul, M Seyrek, B Yalcin, A Ulugol Progress in Neuro-Psychopharmacology and Biological Psychiatry 38 (1), 97-105, 2012 | 58 | 2012 |